Vietnam-focused private equity firm Mekong Capital has invested $25 million in biotech company Entobel.
The investment was routed through the $246-million Mekong Enterprise Fund IV (MEF IV) and was part of Entobel’s $30-million funding round, Mekong Capital said in a statement. The remaining $5 million has been invested by local asset manager Dragon Capital.
